Journal of Cachexia Sarcopenia and Muscle

Papers
(The TQCC of Journal of Cachexia Sarcopenia and Muscle is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis437
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021314
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults211
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review163
COVID‐19: a major cause of cachexia and sarcopenia?138
Understanding the gut microbiota and sarcopenia: a systematic review136
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19124
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis123
The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.102
Effects of statins on mitochondrial pathways102
Mouse models of sarcopenia: classification and evaluation95
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers90
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis87
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study84
Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis77
Muscle wasting as an independent predictor of survival in patients with chronic heart failure77
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults76
Muscular weakness and muscle wasting in the critically ill76
Associations of low handgrip strength with cancer mortality: a multicentre observational study74
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality73
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting70
Gut microbes and muscle function: can probiotics make our muscles stronger?70
Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy67
Sarcopenia and peripheral arterial disease: a systematic review66
Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis65
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients64
Roles of nutrition in muscle health of community‐dwelling older adults: evidence‐based expert consensus from Asian Working Group for Sarcopenia62
Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis62
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China62
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial61
Prevalence of protein intake below recommended in community‐dwelling older adults: a meta‐analysis across cohorts from the PROMISS consortium60
Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study60
Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle59
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study59
Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS58
Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women57
Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study56
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis56
Improving rehabilitation in sarcopenia: a randomized‐controlled trial utilizing a muscle‐targeted food for special medical purposes56
Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review55
Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project55
How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review53
Muscle memory: myonuclear accretion, maintenance, morphology, and miRNA levels with training and detraining in adult mice52
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?52
Age‐related decline of interferon‐gamma responses in macrophage impairs satellite cell proliferation and regeneration52
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)51
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis49
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis49
Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia48
Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis47
Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 mice47
Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a46
ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke45
Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐744
The effect of fasting or calorie restriction on mitophagy induction: a literature review44
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies43
Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study43
Muscle density discriminates hip fracture better than computed tomography X‐ray absorptiometry hip areal bone mineral density43
Age‐related alterations in muscle architecture are a signature of sarcopenia: the ultrasound sarcopenia index43
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle42
A systematic review examining the relationship between cytokines and cachexia in incurable cancer42
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer41
The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis41
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models41
Prognostic impact of muscle and fat mass in patients with heart failure40
The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review40
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia40
TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration39
Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults38
Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire38
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome38
Subtypes of physical frailty and their long‐term outcomes: a longitudinal cohort study37
Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study37
Incidence of cardiovascular disease and mortality in underweight individuals37
lncMGPF is a novel positive regulator of muscle growth and regeneration37
Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset36
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper fromthe International Lipid Expert Panel(ILEP)36
Activation of Akt–mTORC1 signalling reverts cancer‐dependent muscle wasting36
Mitochondrial dysfunction in skeletal muscle contributes to the development of acute insulin resistance in mice36
Higher dietary fibre intake is associated with increased skeletal muscle mass and strength in adults aged 40 years and older36
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin35
Cancer cachexia in a mouse model of oxidative stress35
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction34
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study34
circRNAome profiling reveals circFgfr2 regulates myogenesis and muscle regeneration via a feedback loop34
Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of34
Relative sit‐to‐stand power: aging trajectories, functionally relevant cut‐off points, and normative data in a large European cohort34
Red meat consumption and risk of frailty in older women34
Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis33
Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial33
Female mice may have exacerbated catabolic signalling response compared to male mice during development and progression of disuse atrophy33
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand33
Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the Hertfordshire Cohort Study33
Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry33
Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo‐controlled D‐Health Trial33
Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review33
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer32
High levels of modified ceramides are a defining feature of murine and human cancer cachexia32
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia32
Effects of β‐hydroxy β‐methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review32
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice31
Decoding the transcriptome of denervated muscle at single‐nucleus resolution31
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes31
Satellite cell self‐renewal in endurance exercise is mediated by inhibition of mitochondrial oxygen consumption31
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?31
Muscle strength is associated with COVID‐19 hospitalization in adults 50 years of age or older31
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research31
Severe loss of mechanical efficiency in COVID‐19 patients31
Ribosome biogenesis and degradation regulate translational capacity during muscle disuse and reloading30
Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice30
Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia30
Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease29
Total and regional fat‐to‐muscle mass ratio measured by bioelectrical impedance and risk of incident type 2 diabetes29
AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology29
Predicted fat mass and lean mass in relation to all‐cause and cause‐specific mortality29
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications29
Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: A systematic review and meta‐analysis29
Role of sarcopenia in the frailty transitions in older adults: a population‐based cohort study29
Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey29
Autophagy in muscle regeneration: potential therapies for myopathies29
Twelve‐year sarcopenia trajectories in older adults: results from a population‐based study29
Absolute and relative grip strength as predictors of cancer: prospective cohort study of 445 552 participants in UK Biobank28
Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia28
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation28
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia28
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey28
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma28
ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia28
Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants28
Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study27
Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity27
Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial27
Handgrip strength asymmetry is associated with the risk of neurodegenerative disorders among Chinese older adults27
Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study27
Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin27
Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study27
The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men27
Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control26
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy25
Protein intake and risk of frailty among older women in the Nurses' Health Study25
Intramuscular adipose tissue in the quadriceps is more strongly related to recovery of activities of daily living than muscle mass in older inpatients25
Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta‐analysis25
Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study25
Sarcopenia as potential biological substrate of long COVID‐19 syndrome: prevalence, clinical features, and risk factors25
Inflammation‐induced cholestasis in cancer cachexia25
Population‐based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study25
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma25
Declines in muscle protein synthesis account for short‐term muscle disuse atrophy in humans in the absence of increased muscle protein breakdown25
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients24
The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project24
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis24
Effects of sarcopenia and malnutrition on morbidity and mortality in gynecologic cancer surgery: results of a prospective study24
Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy24
Impact of high‐intensity interval training with or without l‐citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults24
Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators23
The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients23
Single‐cell deconstruction of post‐sepsis skeletal muscle and adipose tissue microenvironments23
Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway23
Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice23
Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study22
Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity22
Differences in the mass and quality of the quadriceps with age and sex and their relationships with knee extension strength22
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy22
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy22
Metabolic profiling shows pre‐existing mitochondrial dysfunction contributes to muscle loss in a model of ICU‐acquired weakness22
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle22
Muscle density is an independent risk factor of second hip fracture: a prospective cohort study22
Impact of probiotics on muscle mass, muscle strength and lean mass: a systematic review and meta‐analysis of randomized controlled trials22
A systematic review and meta‐analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia22
Prognostic significance of surgery‐induced sarcopenia in the survival of gastric cancer patients: a sex‐specific analysis22
Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis22
Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice21
Loss of REDD1 prevents chemotherapy‐induced muscle atrophy and weakness in mice21
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)21
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility21
A randomized, feasibility trial of an exercise and nutrition‐based rehabilitation programme (ENeRgy) in people with cancer21
A subset of microRNAs in the Dlk1‐Dio3 cluster regulates age‐associated muscle atrophy by targeting Atrogin‐121
The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle21
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial21
Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia20
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies20
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop20
Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular disease20
Mitochondria transplant therapy improves regeneration and restoration of injured skeletal muscle20
Validating muscle mass cutoffs of four international sarcopenia‐working groups in Japanese people using DXA and BIA20
Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease20
Vitamin D3supplementation does not enhance the effects of resistance training in older adults20
Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients20
Whole‐body and adipose tissue metabolic phenotype in cancer patients20
Associations between frailty trajectories and frailty status and adverse outcomes in community‐dwelling older adults20
Mitochondrial aberrations during the progression of disuse atrophy differentially affect male and female mice20
Is muscle and protein loss relevant in long‐term fasting in healthy men? A prospective trial on physiological adaptations20
Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease20
Androgen receptor coordinates muscle metabolic and contractile functions19
Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index19
Iron accumulation in skeletal muscles of old mice is associated with impaired regeneration after ischaemia–reperfusion damage19
Sleep duration and progression to sarcopenia in Japanese community‐dwelling older adults: a 4 year longitudinal study19
Recent sarcopenia definitions—prevalence, agreement and mortality associations among men: Findings from population‐based cohorts19
The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab19
Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults19
Muscle mass and estimates of renal function: a longitudinal cohort study19
The composition of the gut microbiome differs among community dwelling older people with good and poor appetite19
Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice19
Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice18
Chronic aryl hydrocarbon receptor activity phenocopies smoking‐induced skeletal muscle impairment18
Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study18
A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK118
Msi2‐mediated MiR7a‐1 processing repression promotes myogenesis18
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience18
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit18
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients17
Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study17
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness17
The time course of disuse muscle atrophy of the lower limb in health and disease17
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps17
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia17
Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes17
Sarcopenia as a prognostic indicator of liver cirrhosis17
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy17
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles17
Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study17
Body composition and osteoporotic fracture using anthropometric prediction equations to assess muscle and fat masses17
Hallmarks of frailty and osteosarcopenia in prematurely aged PolgA(D257A/D257A) mice17
Body composition reference ranges in community‐dwelling adults using dual‐energy X‐ray absorptiometry: the Australian Body Composition (ABC) Study17
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS17
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia17
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice16
Association between the quality of plant‐based diets and risk of frailty16
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study16
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system16
Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)16
Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients16
Blended home‐based exercise and dietary protein in community‐dwelling older adults: a cluster randomized controlled trial16
Chemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes16
D3‐creatine dilution for skeletal muscle mass measurement: historical development and current status16
Transcriptomic meta‐analysis of disuse muscle atrophy vs. resistance exercise‐induced hypertrophy in young and older humans16
Activated mast cells in skeletal muscle can be a potential mediator for cancer‐associated cachexia16
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity16
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis16
Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial16
Association of anorexia/appetite loss with malnutrition and mortality in older populations: A systematic literature review16
Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma16
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles16
Acute skeletal muscle loss in SARS‐CoV‐2 infection contributes to poor clinical outcomes in COVID‐19 patients16
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis16
Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models16
0.054183959960938